Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα
In this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the stat...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/24/13474 |
_version_ | 1797503833438420992 |
---|---|
author | Matej Janežič Katja Valjavec Kaja Bergant Loboda Barbara Herlah Iza Ogris Mirijam Kozorog Marjetka Podobnik Simona Golič Grdadolnik Gerhard Wolber Andrej Perdih |
author_facet | Matej Janežič Katja Valjavec Kaja Bergant Loboda Barbara Herlah Iza Ogris Mirijam Kozorog Marjetka Podobnik Simona Golič Grdadolnik Gerhard Wolber Andrej Perdih |
author_sort | Matej Janežič |
collection | DOAJ |
description | In this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the static structure-based-pharmacophore information with a dynamic component. Subsequently, derived pharmacophore models were employed in a virtual screening campaign of a library of natural compounds. Experimental evaluation identified flavonoid compounds with promising topoisomerase IIα catalytic inhibition and binding studies confirmed interaction with the ATPase domain. We constructed a binding model through docking and extensively investigated it with molecular dynamics MD simulations, essential dynamics, and MM-GBSA free energy calculations, thus reconnecting the new results to the initial dynophore-based screening model. We not only demonstrate a new design strategy that incorporates a dynamic component of molecular recognition, but also highlight new derivates in the established flavonoid class of topoisomerase II inhibitors. |
first_indexed | 2024-03-10T03:56:00Z |
format | Article |
id | doaj.art-d9e7b114d1e74972aed9ab20e7944e36 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T03:56:00Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-d9e7b114d1e74972aed9ab20e7944e362023-11-23T08:46:51ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122241347410.3390/ijms222413474Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIαMatej Janežič0Katja Valjavec1Kaja Bergant Loboda2Barbara Herlah3Iza Ogris4Mirijam Kozorog5Marjetka Podobnik6Simona Golič Grdadolnik7Gerhard Wolber8Andrej Perdih9National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2-4, 14195 Berlin, GermanyNational Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, SloveniaIn this study, we utilized human DNA topoisomerase IIα as a model target to outline a dynophore-based approach to catalytic inhibitor design. Based on MD simulations of a known catalytic inhibitor and the native ATP ligand analog, AMP-PNP, we derived a joint dynophore model that supplements the static structure-based-pharmacophore information with a dynamic component. Subsequently, derived pharmacophore models were employed in a virtual screening campaign of a library of natural compounds. Experimental evaluation identified flavonoid compounds with promising topoisomerase IIα catalytic inhibition and binding studies confirmed interaction with the ATPase domain. We constructed a binding model through docking and extensively investigated it with molecular dynamics MD simulations, essential dynamics, and MM-GBSA free energy calculations, thus reconnecting the new results to the initial dynophore-based screening model. We not only demonstrate a new design strategy that incorporates a dynamic component of molecular recognition, but also highlight new derivates in the established flavonoid class of topoisomerase II inhibitors.https://www.mdpi.com/1422-0067/22/24/13474human DNA topoisomerase IIαcatalytic inhibitorsdynophore modelsdrug designmolecular simulationscancer research |
spellingShingle | Matej Janežič Katja Valjavec Kaja Bergant Loboda Barbara Herlah Iza Ogris Mirijam Kozorog Marjetka Podobnik Simona Golič Grdadolnik Gerhard Wolber Andrej Perdih Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα International Journal of Molecular Sciences human DNA topoisomerase IIα catalytic inhibitors dynophore models drug design molecular simulations cancer research |
title | Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα |
title_full | Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα |
title_fullStr | Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα |
title_full_unstemmed | Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα |
title_short | Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα |
title_sort | dynophore based approach in virtual screening a case of human dna topoisomerase iiα |
topic | human DNA topoisomerase IIα catalytic inhibitors dynophore models drug design molecular simulations cancer research |
url | https://www.mdpi.com/1422-0067/22/24/13474 |
work_keys_str_mv | AT matejjanezic dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT katjavaljavec dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT kajabergantloboda dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT barbaraherlah dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT izaogris dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT mirijamkozorog dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT marjetkapodobnik dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT simonagolicgrdadolnik dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT gerhardwolber dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia AT andrejperdih dynophorebasedapproachinvirtualscreeningacaseofhumandnatopoisomeraseiia |